COPA and cervical cancer: Based on quantification of the following two unique peptides: GITGVDLFGTTDAVVK (Fig. 3A) and CPLSGACYSPEFK (Fig. 3B), COPA was verified as a potential biomarker of cervical cancer via targeted proteomics.